Pure Global AI
NCT06211361Not yet recruiting

Cardiac Rehabilitation Program in Patients With Cardiovascular Disease

Impact of a Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
University of Castilla-La ManchaClinicalTrials.govother
Study focus
Drug/Device/Intervention
Cardiac rehabilitation
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Castilla-La Mancha
Location
Cuenca, Spain
Timeline & enrollment
Phase
N/A
Start date
Jan 08, 2024
End date
Mar 30, 2024
Enrollment
80 participants
Primary outcome

Change in peak oxygen uptake,Change in cardiorespiratory fitness

Summary

This protocol study aims to evaluate the effectiveness of a cardiac rehabilitation
 intervention program in patients with cardiovascular diseases to improve both anthropometric
 and biochemical data, as well as other variables related to cardiovascular disorders
 (cardiorespiratory fitness, muscle strength, …), and emotional aspects (anxiety, depression).
 
 Additionally, this study aims to evaluate the effectiveness of the cardiac rehabilitation
 program in improving body composition (waist circumference and body fat percentage), blood
 pressure and health-related quality of life.
 
 Objectives: i) To assess the functional capacity of patients with a recent cardiovascular
 event (acute coronary syndrome, onset heart failure, valve or bypass surgery) or with chronic
 decompensated cardiovascular disease (valvulopathy, pulmonary hypertension, congenital heart
 disease, heart failure) chronic), ii) to determine the different cardiorespiratory parameters
 obtained from cardiopulmonary exercise testing (CPET), iii) to determine the lifestyle habits
 and cardiovascular risk factors, iv) to develop a cardiac rehabilitation program according to
 and adapted to the need of each of these patients, v) to estimate the effect of the
 intervention, both in the muscle strength and in post-intervention CPET, biochemical and
 anthropometric parameters, v) to estimate the effect of the intervention in the quality of
 life, anxiety, depression, and adherence to the Mediterranean diet.

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseOther ill-defined heart diseasesHeart disease, unspecifiedObservation for other suspected cardiovascular diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06211361
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06211361 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Castilla-La Mancha and is currently Not yet recruiting. The study focuses on Cardiovascular Diseases. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.